Search - tctmd.com

Displaying 61 - 80 of 392

Sort: Relevancy | Date

News Daily News

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Michael O'Riordan

July 16, 2018

News Conference News EAS 2018

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Yael L. Maxwell

May 14, 2018

News Daily News

Abciximab in ‘Short Supply’ Worldwide

Shelley Wood

April 13, 2018

News Daily News

Drug for Rare Form of Cardiomyopathy Meets Primary Endpoint in Phase III Trial

Todd Neale

March 30, 2018

News Daily News

European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban

Todd Neale

March 23, 2018

News Conference News ESC 2017

Inclisiran Offers Sustained LDL-Lowering Through 1 Year: ORION-1

Michael O'Riordan

September 05, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Conference News SCAI 2017

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

L.A. McKeown

May 12, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Shelley Wood

May 05, 2017

News Conference News ACC 2017

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

Yael L. Maxwell

March 17, 2017

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

News Daily News

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

Michael O'Riordan

November 09, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

News Daily News

En la Frontera de las PCI para el Manejo de OTC para Pacientes STEMI: Las Respuestas Llevan a Más Preguntas en el EXPLORE

Yael L. Maxwell

October 05, 2016

News Daily News

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Shelley Wood

October 03, 2016

News Daily News

MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST

Shelley Wood

October 03, 2016

News Daily News

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

Todd Neale

September 28, 2016

Advertisement

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Abciximab in ‘Short Supply’ Worldwide

Drug for Rare Form of Cardiomyopathy Meets Primary Endpoint in Phase III Trial

European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban

Inclisiran Offers Sustained LDL-Lowering Through 1 Year: ORION-1

ESC Updates Guidelines for Treating STEMI Patients

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

En la Frontera de las PCI para el Manejo de OTC para Pacientes STEMI: Las Respuestas Llevan a Más Preguntas en el EXPLORE

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content